U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562789) titled 'Role of PCGEM1 in Breast Cancer' on April 26. Brief Summary: This study examines certain mol... और पढ़ें
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562035) titled 'Endoscopic Versus Conventional Lumbar Decompression for Lumbar Canal Stenosis' on April 21. ... और पढ़ें
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07563218) titled 'I-TOPS With Patients With Genetic Syndrome SYN-TOPS' on April 13. Brief Summary: Genetic syn... और पढ़ें
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07563023) titled 'Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA... और पढ़ें
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561606) titled 'Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea' on April 25. Br... और पढ़ें
Singapore, May 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... और पढ़ें
Singapore, May 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... और पढ़ें
Singapore, May 2 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... और पढ़ें
Singapore, May 2 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post... और पढ़ें
Singapore, May 2 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) ... और पढ़ें